Journal
SUBSTANCE ABUSE
Volume 33, Issue 1, Pages 40-47Publisher
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/08897077.2011.620475
Keywords
Buprenorphine; opioid dependence; re-entry; primary care; criminal justice
Categories
Funding
- New York City Department of Health and Mental Hygiene
- New York City Health and Hospitals Corporation
- NIDA [R21-DA020583]
- Cephalon
- Alkermes Inc.
- Bellevue Hospital Center
- NATIONAL INSTITUTE ON DRUG ABUSE [R21DA020583] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Primary care is understudied as a reentry drug and alcohol treatment setting. This study compared treatment retention and opioid misuse among opioid-dependent adults seeking buprenorphine/naloxone maintenance in an urban primary care clinic following release from jail versus community referrals. Postrelease patients were either (a) induced to buprenorphine in-jail as part of a clinical trial, or (b) seeking buprenorphine induction post release. From 2007 to 2008, N = 142 patients were new to primary care buprenorphine: n = 32 postrelease; n = 110 induced after community referral and without recent incarceration. Jail-released patients were more likely African American or Hispanic and uninsured. Treatment retention rates for postrelease (37%) versus community (30%) referrals were similar at 48 weeks. Rates of opioid positive urines and self-reported opioid misuse were also similar between groups. Postrelease patients in primary care buprenorphine treatment had equal treatment retention and rates of opioid abstinence versus community-referred patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available